School of Medicine

Washington University student group IDEA Labs received the Spirit of St. Louis Award at the St. Louis Regional Chamber’s 2016 Arcus Awards for advancing the city’s rich history and global reputation as a hub of innovation and forward-looking vision.

New research at the School of Medicine indicates that initial levels of omega-3 fatty acids in a heart patient’s blood have a significant impact on whether that person will respond to omega-3 supplements to treat depression.

Two Washington University researchers, Elaine Mardis and Ann Gronowski, have been recognized by the American Association for Clinical Chemistry for exceptional research and service in the field of laboratory medicine.

In two studies led by researchers at the School of Medicine, scientists have identified intestinal bacteria and viruses as possible sources of inflammation and disease related to HIV-related infections.

An imbalance of certain gut microbes appears to be the underlying cause of a frequently fatal intestinal illness in premature babies, according to new research led by Washington University School of Medicine in St. Louis.

Paul F. Austin, MD, a professor of surgery at Washington University School of Medicine in St. Louis, will receive the John W. Duckett Pediatric Research Excellence Award from the American Urology Association’s Urology Care Foundation.

A new Washington University School of Medicine study reveals extensive antibiotic resistance in the gut bacteria of premature infants. The researchers say these findings support the push to minimize routine use of antibiotics in these patients.

ARCH Air Medical Services has announced that H. Philip Moy, MD, clinical instructor in emergency medicine at Washington University School of Medicine in St. Louis, will serve as medical director for its Missouri operations.

New guidelines from the American Heart Association and the American College of Cardiology loosened some restrictions on athletes with heart conditions. Cardiologists at the School of Medicine led two of the task forces responsible for updating the guidelines.

A new study that included genetic data from more than 190,000 people has identified two genes that, when altered in specific ways, either promote or undermine cardiovascular health. The findings may help guide efforts to design new preventive drugs, similar to the way statins now are prescribed to lower “bad” cholesterol to reduce the risk of heart disease.